Abbott Laboratories Operating Margin vs. Shares Owned By Insiders

ABT Stock  USD 102.19  0.45  0.44%   
Based on Abbott Laboratories' profitability indicators, Abbott Laboratories is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in July. Profitability indicators assess Abbott Laboratories' ability to earn profits and add value for shareholders.

Abbott Laboratories Operating Profit Margin

0.21

At this time, Abbott Laboratories' Price To Sales Ratio is comparatively stable compared to the past year. EV To Sales is likely to gain to 5.25 in 2024, whereas Days Of Sales Outstanding is likely to drop 50.27 in 2024. At this time, Abbott Laboratories' Total Other Income Expense Net is comparatively stable compared to the past year. Net Income Applicable To Common Shares is likely to gain to about 8.4 B in 2024, whereas Income Before Tax is likely to drop slightly above 3.8 B in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.620.5518
Moderately Up
Pretty Stable
Net Profit Margin0.150.1427
Sufficiently Up
Very volatile
Operating Profit Margin0.210.1615
Significantly Up
Pretty Stable
Pretax Profit Margin0.210.1661
Significantly Up
Pretty Stable
Return On Assets0.120.0782
Way Up
Very volatile
Return On Equity0.260.1483
Way Up
Very volatile
For Abbott Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Abbott Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Abbott Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Abbott Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Abbott Laboratories over time as well as its relative position and ranking within its peers.
  

Abbott Laboratories' Revenue Breakdown by Earning Segment

Check out Trending Equities.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
2.12
Earnings Share
3.21
Revenue Per Share
23.181
Quarterly Revenue Growth
0.022
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Abbott Laboratories Shares Owned By Insiders vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Abbott Laboratories's current stock value. Our valuation model uses many indicators to compare Abbott Laboratories value to that of its competitors to determine the firm's financial worth.
Abbott Laboratories is rated below average in operating margin category among related companies. It is number one stock in shares owned by insiders category among related companies making about  3.45  of Shares Owned By Insiders per Operating Margin. At this time, Abbott Laboratories' Operating Profit Margin is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Abbott Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abbott Laboratories' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abbott Laboratories' earnings, one of the primary drivers of an investment's value.

Abbott Laboratories' Earnings Breakdown by Geography

Abbott Shares Owned By Insiders vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Abbott Laboratories

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.15 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Abbott Laboratories

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
0.53 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Abbott Shares Owned By Insiders Comparison

Abbott Laboratories is currently under evaluation in shares owned by insiders category among related companies.

Abbott Laboratories Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Abbott Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Abbott Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Abbott Laboratories' change in net profit over the period of time. It can combine multiple indicators of Abbott Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-7.8 B-7.4 B
Operating Income6.5 B3.8 B
Income Before Tax6.7 B3.8 B
Total Other Income Expense Net438 M459.9 M
Net Income5.7 B3.3 B
Income Tax Expense941 M792.1 M
Net Income Applicable To Common SharesB8.4 B
Net Income From Continuing Ops5.2 B4.3 B
Non Operating Income Net Other577.3 M606.2 M
Interest Income384 M269 M
Net Interest Income-248 M-260.4 M
Change To Netincome787.8 M827.1 M
Net Income Per Share 3.29  3.45 
Income Quality 1.27  1.47 
Net Income Per E B T 0.86  0.63 

Abbott Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Abbott Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Abbott Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Abbott Laboratories' important profitability drivers and their relationship over time.

Use Abbott Laboratories in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Abbott Laboratories Pair Trading

Abbott Laboratories Pair Trading Analysis

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Abbott Laboratories position

In addition to having Abbott Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wireless Thematic Idea Now

Wireless
Wireless Theme
Companies providing wireless technology and communication services. The Wireless theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out Trending Equities.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
To fully project Abbott Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Abbott Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Abbott Laboratories' income statement, its balance sheet, and the statement of cash flows.
Potential Abbott Laboratories investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Abbott Laboratories investors may work on each financial statement separately, they are all related. The changes in Abbott Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbott Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.